Kampanjeplan Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Om selskapet
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited вместе со своими дочерними компаниями занимается исследованием, разработкой, производством и продажей китайских патентованных и западных лекарств, химического сырья, натуральных и биологических лекарств и промежуточных продуктов химического сырья в Китайской Народной Республике. Китае и на международном уровне. Компания работает в четырех сегментах: Great Southern Medicine, Great Commerce, Great Health и Great Medical Care. Flere detaljerEBITDA | 4.2 |
---|---|
EV/EBITDA | 6.31 |
ISIN | CNE100000387 |
Industry | Pharmaceuticals |
P/BV | 1.51 |
P/E | 12.27 |
P/S | 0.6025 |
Sector | Health Care |
Валюта | hkd |
Валюта отчета | cny |
Выручка | 64.95 |
Див.доход ао | 3.66 |
Дивиденд ао | 0.81 |
Сайт | https://www.gybys.com.cn |
Цена ао | 17.34 |
Число акций ао | 1.62579 млрд |
Prisendring per dag: | -0.7718% (18.14) |
---|---|
Prisendring per uke: | -0.5525% (18.1) |
Prisendring per måned: | -3.85% (18.72) |
Prisendring over 3 måneder: | +1.58% (17.72) |
Prisendring over seks måneder: | -22.25% (23.15) |
Prisendring per år: | -11.98% (20.45) |
Prisendring over 3 år: | -4.86% (18.92) |
Prisendring over 5 år: | -32.96% (26.85) |
Prisendring siden begynnelsen av året: | -13.04% (20.7) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Vanguard International Stock Index-Total Intl Stock Indx | 3131267 | 1.42 |
Vanguard International Stock Index-Emerging Markets Stk | 2597825 | 1.18 |
DFA Emerging Markets Core Equity Portfolio | 1082000 | 0.49 |
Goldman Sachs Emerging Markets Equity Insights Fund | 1056000 | 0.48 |
DFA Investment Dimensions-DFA Emerging Mkts Value | 624000 | 0.28 |
Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 502620 | 0.23 |
DFA Emerging Markets Small Cap Series | 456000 | 0.21 |
Nationwide Var Ins Tr-NVIT GS Emerging Markets Insights Fd | 444000 | 0.2 |
Schwab Strategic Tr-Schwab Emerging Markets Equity ETF | 251442 | 0.11 |
DFA Emerging Markets Series | 230000 | 0.1 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
Loncar China BioPharma ETF | 1.99 | 18434.246575342 | |
FINEX CHINA UCITS ETF | 0.03 | -34.73 | |
Dimensional Emerging Markets Core Equity 2 ETF | 0.00871 | 15.961857379768 | 3.34087 |
Franklin FTSE Asia ex Japan ETF | 0.00778 | 14.428333729498 | 2.66768 |
Franklin FTSE China ETF | 0.02432 | 14.495305164319 | 3.35323 |
SPDR S&P China ETF | 0.03462 | 10.564102564103 | 3.40103 |
JPMorgan Diversified Return Emerging Markets Equity ETF | 0.04645 | 7.2041905514924 | 5.1761 |
Vanguard ESG International Stock ETF | 0 | 9.456664786614 | 3.07501 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Hong Li | GM & Executive Director | 1.63M | 1967 (57 år) |
Ms. Ning Cheng | Executive Vice Chairman | N/A | 1966 (58 år) |
Mr. Jun Yang | Executive Vice Chairman | N/A | 1970 (54 år) |
Mr. Changhai Wu | Deputy GM & Executive Director | 412.12k | 1966 (58 år) |
Ms. Juyan Liu | Executive Director | N/A | 1964 (60 år) |
Ms. Haoshan Zheng | Deputy GM & Director of Business Administration Department | N/A | 1976 (48 år) |
Ms. Xuezhen Huang | Secretary | N/A | 1974 (50 år) |
Adresse: China, Guangzhou, No. 45 Shamian North Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.gybys.com.cn
Nettsted: https://www.gybys.com.cn